The federal chief of AIDS research says he believes drug companies don’t have an incentive to create a vaccine for HIV and are likely to wait to profit from it after the government develops one, according to the Associated Press.
“We had to spend some time and energy paying attention to those aspects of development because the private side isn’t picking it up,” Dr. Edmund Tramont testified in a deposition in a recent lawsuit obtained by the Associated Press.
Tramont is head of the AIDS research division of the National Institutes of Health.
For a full story, click here.
Pictured: Edmund Tramont.
